Cargando…

Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey

Lipid-lowering in patients with coronary artery disease (CAD) is related to a lower risk of cardiovascular events. We evaluated factors related to the management of hypercholesterolemia in patients with established CAD. Patients were interviewed 6–18 months after hospitalization for an acute coronar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jankowski, Piotr, Kozieł, Paweł, Setny, Małgorzata, Paniczko, Marlena, Haberka, Maciej, Banach, Maciej, Bacquer, Dirk De, Backer, Guy De, Kotseva, Kornelia, Wood, David, Gąsior, Zbigniew, Kamiński, Karol, Kosior, Dariusz A., Pająk, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396933/ https://www.ncbi.nlm.nih.gov/pubmed/34442006 http://dx.doi.org/10.3390/jcm10163711

Ejemplares similares

Management of Dyslipidemia in Women and Men with Coronary Heart Disease: Results from POLASPIRE Study
por: Setny, Małgorzata, et al.
Publicado: (2021)

Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus – Polish multicenter study POLASPIRE
por: Haberka, Maciej, et al.
Publicado: (2020)

Undiagnosed Diabetes and Prediabetes in Patients with Chronic Coronary Syndromes—An Alarming Public Health Issue
por: Drobek, Natalia, et al.
Publicado: (2021)

Recollection of Physician Information about Risk Factor and Lifestyle Changes in Chronic Coronary Syndrome Patients
por: Sinnadurai, Siamala, et al.
Publicado: (2022)

Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV
por: Gyberg, Viveca, et al.
Publicado: (2016)

Two-dimensional speckle-tracking echocardiography assessment of left ventricular remodeling in patients after myocardial infarction and primary reperfusion
por: Liszka, Jerzy, et al.
Publicado: (2014)

Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology
por: Shahim, Bahira, et al.
Publicado: (2018)

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA(1c) in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology
por: Shahim, Bahira, et al.
Publicado: (2017)

COVID-19 Vaccine Hesitancy in Poland—Multifactorial Impact Trajectories
por: Sowa, Paweł, et al.
Publicado: (2021)

Adiposity, fat depots and the prediction of stroke
por: Haberka, Maciej, et al.
Publicado: (2023)

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
por: Ferrannini, Giulia, et al.
Publicado: (2021)

Malignancy-Associated Dyslipidemia
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2011)

RNA Silencing in the Management of Dyslipidemias
por: Henney, Neil C., et al.
Publicado: (2021)

Tricuspid valve resection without replacement: An asymptomatic severe right ventricle dysfunction 16 years after surgery
por: Olejnik, Aleksander, et al.
Publicado: (2022)

Validity and reliability of the HeartQoL questionnaire based on the EUROASPIRE IV study
por: De Smedt, Delphine, et al.
Publicado: (2015)

Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts’ opinion. The compromise between EBM and possibilities in healthcare
por: Banach, Maciej, et al.
Publicado: (2022)

Contemporary Management of Dyslipidemia
por: Ferraro, Richard A., et al.
Publicado: (2022)

Long-term survival with good functional capacity in unoperated complex congenital heart defect with balanced systemic and pulmonary circulation
por: Haberka, Maciej, et al.
Publicado: (2014)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions: In Partnership with the World Heart Federation, European Society of Cardiology, Asia Pacific Society of Cardiology, InterAmerican Society of Cardiology, and PanAfrican Society of Cardiology.
por: McEvoy, John William, et al.
Publicado: (2021)

Carotid intima-media thickness in patients with mild or moderate psoriasis
por: Bańska-Kisiel, Katarzyna, et al.
Publicado: (2016)

Serum ADMA concentration – an independent factor determining FMD impairment in cardiac syndrome X
por: Haberka, Maciej, et al.
Publicado: (2009)

Body mass index and waist circumference in patients with established coronary artery disease over a 20-year period
por: Jankowski, Piotr, et al.
Publicado: (2023)

Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
por: Szpakowicz, Anna, et al.
Publicado: (2021)

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023)

N-3 Polyunsaturated fatty acid therapy improves endothelial function and affects adiponectin and resistin balance in the first month after myocardial infarction
por: Mizia-Stec, Katarzyna, et al.
Publicado: (2011)

A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
por: Chlabicz, Małgorzata, et al.
Publicado: (2021)

Angiopoietin-2 as a biomarker of non-ST-segment elevation myocardial infarction in patients with or without type 2 diabetes
por: Skowerski, Tomasz, et al.
Publicado: (2019)

ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK
por: Jennings, Catriona S, et al.
Publicado: (2020)

Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (a retrospective analysis of the EUROACTION trial)
por: Ofori, Sandra N, et al.
Publicado: (2015)

An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis
por: Wasiak, Michał, et al.
Publicado: (2023)

Independent Impact of Gynoid Fat Distribution and Free Testosterone on Circulating Levels of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in Humans
por: Chlabicz, Małgorzata, et al.
Publicado: (2019)

Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data
por: Lewek, Joanna, et al.
Publicado: (2023)

FOXO1 and ANGPT2 relative gene expression in non-ST-segment elevation myocardial infarction among patients with or without type 2 diabetes
por: Skowerski, Tomasz, et al.
Publicado: (2021)

PCSK9 inhibitors – from discovery of a single mutation to a groundbreaking therapy of lipid disorders in one decade
por: Jaworski, Krzysztof, et al.
Publicado: (2017)

Underlying Causes of Myocardial Infarction with Nonobstructive Coronary Arteries: Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging Pilot Study
por: Fluder-Wlodarczyk, Joanna, et al.
Publicado: (2022)

Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes
por: Paniczko, Marlena, et al.
Publicado: (2020)

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
por: Banach, Maciej, et al.
Publicado: (2022)

Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
por: Mistry, Hema, et al.
Publicado: (2012)

ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk
por: Chlabicz, Małgorzata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tl6fpv40fg1leqpb53u8ku0al1